Advanced search
Publication Cover
Acta Cardiologica Volume 73, 2018 - Issue 6
Submit an article Journal homepage
76
Views
0
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Quality assessment in Belgian ST elevation myocardial infarction patients: results from the Belgian STEMI database

Marc J. ClaeysDepartment of Cardiology, University Hospital Antwerp, Edegem, Belgium; Correspondence[email protected]
,
Peter R. SinnaeveDepartment of Cardiology, UZ Leuven, Leuven, Belgium;
,
Carl ConvensDepartment of Cardiology, ZNA Antwerpen, Antwerp, Belgium;
,
Philippe DuboisDepartment of Cardiology, CHU Charleroi, Charleroi, Belgium;
,
Suzanne PourbaixDepartment of Cardiology, CHR Citadelle Liège, Liège, Belgium;
,
Pascal VranckxDepartment of Cardiology, Virga Jesse Hasselt, Hasselt, Belgium;
,
Sofie GevaertDepartment of Cardiology, UZ Gent, Gent, Belgium;
,
Herbert De RaedtDepartment of Cardiology, OLV Ziekenhuis Aalst, Aalst, Belgium;
,
Christophe BeauloyeDepartment of Cardiology, UCL Louvain, Louvain, Belgium;
,
Jean-Francois ArgachaDepartment of Cardiology, UZ Brussels, Brussels, Belgium;
,
Patrick EvrardDepartment of Cardiology, UCL Mont-Godinne, Yvoir, Belgium;
&
Patrick CoussementDepartment of Cardiology, AZ Brugge, Brugge, Belgium
 show all
Pages 529-533 | Received 24 Oct 2017, Accepted 02 Dec 2017, Published online: 11 Dec 2017

References

  • Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–2619.
  • Claeys MJ, Legrand V, Mairesse GH, et al. Summary 2014 ESC guidelines. Acta Cardiol. 2015;70:73–79.
  • Claeys MJ, Sinnaeve PR, Convens C, et al. STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme. Eur Heart J Acute Cardiovasc Care. 2012;1:40–47.
  • Claeys MJ, Gevaert S, De Meester A, et al. Implementation of reperfusion therapy in ST-segment elevation myocardial infarction. A policy statement from the Belgian society of cardiology (BSC), the Belgian interdisciplinary working group on acute cardiology (BIWAC) and the Belgian working group on interventional cardiology (BWGIC). Acta Cardiol. 2009;64:541–545.
  • Schiele F, Gale CP, Bonnefoy E, et al. Quality indicators for acute myocardial infarction: a position paper of the acute cardiovascular care association. Eur Heart J Acute Cardiovasc Care. 2017;6:34–59.
  • Kristensen SD, Laut KG, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. Eur Heart J. 2014;35:1957–1970.
  • Vora AN, Holmes DN, Rokos I, et al. Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US national cardiovascular data registry. JAMA Intern Med. 2015;175:207–215.
  • Bebb O, Hall M, Fox KAA, et al. Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register. Eur Heart J. 2017;38:974–982.
  • Brown JP, Mahmud E, Dunford JV, et al. Effect of prehospital 12-lead electrocardiogram on activation of the cardiac catheterization laboratory and door-to-balloon time in ST-segment elevation acute myocardial infarction. Am J Cardiol. 2008;101:158–161.
  • Danchin N, Lettino M, Zeymer U, et al. Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. Eur Heart J Cardiovasc Pharmacother. 2016;2:152–167.
  • Danchin N, Puymirat E, Steg PG, et al. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort. Circulation. 2014;129:1629–1636.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.